Loading…
Lexicon Pharmaceuticals, Inc. is projected to rise to $3.16 by 2027, a +42% move from its current price of $2.22. LXRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.15 | $2.22 | $2.30 | +0.12% |
| Jul 14 | $2.12 | $2.23 | $2.34 | +0.24% |
| Jul 15 | $2.10 | $2.23 | $2.37 | +0.36% |
| Jul 16 | $2.08 | $2.23 | $2.39 | +0.48% |
| Jul 17 | $2.06 | $2.23 | $2.42 | +0.60% |
| Jul 18 | $2.05 | $2.24 | $2.44 | +0.72% |
| Jul 19 | $2.04 | $2.24 | $2.46 | +0.84% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.04 | $2.24 | $2.46 | +0.84% |
| Week 2 | $1.98 | $2.26 | $2.58 | +1.68% |
| Week 3 | $1.94 | $2.28 | $2.68 | +2.53% |
| Week 4 | $1.90 | $2.30 | $2.77 | +3.38% |
| Week 5 | $1.88 | $2.31 | $2.85 | +4.25% |
| Week 6 | $1.86 | $2.33 | $2.93 | +5.12% |
| Week 7 | $1.84 | $2.35 | $3.01 | +6.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lexicon Pharmaceuticals, Inc., LXRX, is a Healthcare biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors.
Lexicon has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
LXRX is currently priced at $2.34 with a market cap of $1.04B, ranking 2552.
The price is trading near the SMA50 of $2.01 and above the SMA200 of $1.57, signaling a near-term upward bias.
The 30-day range is $1.79 to $3.06, and RSI14 is 60.
The long-term outlook shows rising averages, with 2026 avg $2.34, 2027 avg $3.33, 2030 avg $6.93, 2040 avg $24.71, and 2050 avg $51.07, with bullish sentiment in the later years.
A major floor 34.8% below — a decisive break under it would weaken the trend.
The nearest floor, 16.7% below — buyers have tended to step in here.
The nearest ceiling, 18.9% above — a clean break opens room to run.
A major ceiling 36.3% above — clearing it would confirm fresh momentum.
Key LXRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LXRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.29 | Sell | $2.27 | Sell |
| MA 10 | $2.37 | Sell | $2.28 | Sell |
| MA 20 | $2.21 | Buy | $2.23 | Sell |
| MA 50 | $2.08 | Buy | $2.09 | Buy |
| MA 100 | $1.86 | Buy | $1.90 | Buy |
| MA 200 | $1.61 | Buy | $1.67 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.42 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 2.66 | Neutral |
| Williams %R (14) | -85.71 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 2.78 | Buy |
| Bollinger %B (20,2) | 0.51 | Neutral |
| Stochastic %K (14) | 14.29 | Buy |
| TRIX (15) | 0.62 | Buy |
| Awesome (5,34) | 0.15 | Buy |
| Ultimate (7,14,28) | 34.40 | Neutral |
| Momentum (10) | -0.07 | Sell |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 2.23 | Sell |
| ADX (14) | 17.90 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture leans bullish. RSI14 is 60, and the price sits above the 50-day moving average of $2.01, above the 200-day moving average of $1.57.
Support is at $1.85 and resistance at $2.64, with a 30-day range of $1.79 to $3.06.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.14 | $2.22 | $3.34 | 0% | Neutral | |
| $2.44 | $3.16 | $4.35 | +42% | Bullish | |
| $3.48 | $4.67 | $6.73 | +110% | Bullish | |
| $4.26 | $5.89 | $8.81 | +166% | Bullish | |
| $4.69 | $6.66 | $10.26 | +200% | Bullish | |
| $4.89 | $7.13 | $11.27 | +221% | Bullish | |
| $5.21 | $7.78 | $12.58 | +250% | Bullish | |
| $6.48 | $9.89 | $16.33 | +345% | Bullish | |
| $7.85 | $12.25 | $20.61 | +452% | Bullish | |
| $8.96 | $14.26 | $24.44 | +543% | Bullish | |
| $13.27 | $23.25 | $42.86 | +947% | Bullish | |
| $24.19 | $50.29 | $103.04 | +21.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.14 | $2.22 | $2.65 | +0.00% |
| August 2026 | $1.95 | $2.32 | $2.85 | +4.60% |
| September 2026 | $2.06 | $2.47 | $3.08 | +6.55% |
| October 2026 | $2.05 | $2.48 | $3.12 | +0.04% |
| November 2026 | $2.03 | $2.47 | $3.15 | -0.10% |
| December 2026 | $2.12 | $2.60 | $3.34 | +5.21% |
Click any year to see its month-by-month LXRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, LXRX is projected to trade between $1.14 and $3.34, averaging $2.22 — a potential gain of 0% from today's $2.22. A consolidation phase looks the most probable path here.
Lexicon Pharmaceuticals, Inc.'s 2027 outlook centres on $3.16, within a $2.44 to $4.35 range. That is up +42% on the projected 2026 average. That marks a +42% change versus current levels. Momentum favours further upside here.
By 2028, LXRX could reach as high as $6.73, with a base case around $4.67 and support toward $3.48 — roughly +110% from $2.22. Buyers look set to stay in control over this stretch.
Expect LXRX to range from $4.26 to $8.81 through 2029. The $5.89 average target implies a +166% move from current prices. That is up +26% on the projected 2028 average. Momentum favours further upside here.
The LXRX price prediction for 2030 points to an average of $6.66 (low $4.69, high $10.26) — a potential gain of +200% on today's $2.22. Buyers look set to stay in control over this stretch.
In 2031, LXRX is projected to trade between $4.89 and $11.27, averaging $7.13 — a potential gain of +221% from today's $2.22. That is up +7% on the projected 2030 average. Momentum favours further upside here.
Lexicon Pharmaceuticals, Inc.'s 2032 outlook centres on $7.78, within a $5.21 to $12.58 range. That is up +9% on the projected 2031 average. That marks a +250% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, LXRX could reach as high as $16.33, with a base case around $9.89 and support toward $6.48 — roughly +345% from $2.22. Momentum favours further upside here.
Expect LXRX to range from $7.85 to $20.61 through 2034. The $12.25 average target implies a +452% move from current prices. That is up +24% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The LXRX price prediction for 2035 points to an average of $14.26 (low $8.96, high $24.44) — a potential gain of +543% on today's $2.22. Momentum favours further upside here.
In 2040, LXRX is projected to trade between $13.27 and $42.86, averaging $23.25 — a potential gain of +947% from today's $2.22. That is up +63% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Lexicon Pharmaceuticals, Inc.'s 2050 outlook centres on $50.29, within a $24.19 to $103.04 range. That is up +116% on the projected 2040 average. That marks a +21.7x change versus current levels. Momentum favours further upside here.
Investing $1,000 in LXRX today (≈ 450.45045 LXRX) could be worth
$22,652.69
+$21,652.69 (+2165%) by 2050 · US Dollar
Based on the average projected LXRX price of $50.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LXRXwould be worth at today's price.
$1,000 invested in LXRX on Jul 10, 2025 (≈ 884.955756 LXRX) would be worth
$1,964.6
+$964.6 (+96.5%) today · 1.96× · US Dollar
Based on a LXRX entry price of $1.13 vs. today's $2.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.32 | $956.9 | -4.3% |
| 1 month ago | $1.88 | $1,180.85 | +18.1% |
| 3 months ago | $1.72 | $1,290.7 | +29.1% |
| 6 months ago | $1.18 | $1,881.36 | +88.1% |
| 1 year ago | $1.13 | $1,964.6 | +96.5% |
| All time (5.0y) ago | $3.88 | $572.16 | -42.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LXRX forecast.
Our base-case forecast reaches $4.40 around 2028.
Implied market cap at $4.40: $1.95B
The multi-year forecast shows upside potential with a neutral stance in 2026: min $1.14, avg $2.34, max $3.67, ROI 0, sentiment NEUTRAL.
In 2030 the average is $6.93 with a min of $4.69 and a max of $11.08, ROI 196, sentiment BULLISH.
In 2040 the average rises to $24.71 (min $12.97, max $48.14), ROI 955.8, sentiment BULLISH.
In 2050 the average is $51.07 (min $22.98, max $111.58), ROI 2082.7, sentiment BULLISH. These figures are estimates, not guarantees.
Tap a question to reveal the answer.
2030 avg $6.93, min $4.69, max $11.08, ROI 196%, sentiment BULLISH.
The 2026 forecast shows min $1.14, avg $2.34, max $3.67 with ROI 0 and neutral sentiment. From 2027 onward, forecasts are bullish with rising averages and ROIs (e.g., 2027 avg $3.33, ROI 42.2%; 2028 avg $5.15, ROI 120.2%).
Yes—the 2026 max is $3.67 and 2027 avg is $3.33, indicating potential to surpass $3 in 2026-2027.
2040 avg $24.71, min $12.97, max $48.14, ROI 955.8%, sentiment BULLISH.
2050 avg $51.07, min $22.98, max $111.58, ROI 2082.7%, sentiment BULLISH.
Lexicon Pharmaceuticals, Inc. Community Discussion
0Share your Lexicon Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.